Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia

Describes Covid-related changed to treatment & preliminary analysis of the association with patients' substance use and well-being.
Original research | 2021
Evidence base, Harm reduction, Safer supply, Advocacy, About prescribers, Outcomes

Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada

We aimed to estimate the impact of policy changes and the announcement of the opioid overdose-related public health emergency on the use of OAT for incarcerated individuals with opioid use disorder.
Original research | 2021
Policy/Regulatory, Legal system/law enforcement, Substitution/OAT

Perspectives of people who use opioids and prescribers on opioid agonist therapy during the pandemic: Findings from the ALT-POP Study

Evaluate the rapid transformation of pandemic-related OAT prescribing patterns from the perspective of people who use opioids and prescribers, including both positive and negative effects.

Slide deck | 2021
Harm reduction, About prescribers, About PWUD, Barriers and enablers, Substitution/OAT, Digital health, Diversion, Carries/take-home doses

Third party drug checking: accessing harm reduction services on the behalf of others

We aim to examine the frequency of third party use of a community drug checking service to explore the potential for harm reduction to extend beyond the individual into the community, increase service
Original research | 2021
Harm reduction, Illegal drugs, Drug checking, Social benefits

Treatment options and shared decision-making in the treatment of opioid use disorder: A scoping review

Shared decision-making (SDM) is an approach to clinical decision-making that includes patients' values and preferences during health-related decisions.
Scoping review | 2021
Clinical guidance, About prescribers, About PWUD

Unsafe Supply: Why Making Controlled Prescription Drugs Available for Unsupervised Use Will Not Target the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19— A Commentary on Bonn et al. (2020)

Commentary on Bonn et all 2020
Commentary | 2020
Safer supply

Using intervention mapping to develop ‘ROSE’: an intervention to support peer workers in overdose response settings

Peer workers (those with lived/living experience of substance use working in overdose response settings) are at the forefront of overdose response initiatives in British Columbia (BC).
Original research | 2021
Harm reduction, Peer/PWLLE program involvement

Which lives are worth saving? Biolegitimacy and harm reduction during COVID-19

This article draws on the theoretical work of Foucault and scholars who further developed his concept of biopolitics.
Commentary | 2021
Safer supply, Decriminalization/legalization, Equity, Advocacy, Housing

“They’re not doing enough.”: women’s experiences with opioids and naloxone in Toronto

Study women's experiences and perspectives on the opioid crisis
Original research | 2021
About PWUD, Legal system/law enforcement, Sex/Gender , Stigma

'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings

This study examines structural vulnerabilities that constrain PWUD as they attempt to implement overdose education and naloxone distribution program advice.
Original research | 2019
Overdose, Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Advocacy, About PWUD, Barriers and enablers, Illegal drugs, Peer/PWLLE program involvement, Sex/Gender , SCS/OPS

Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011

Assess whether state medical cannabis laws were associated with reduced risk of fatal opioid overdose between 2000-2011.
Original research | 2022
Mortality, Policy/Regulatory, Barriers and enablers, Illegal drugs

Canada's overdose crisis: authorities are not acting fast enough

Response to Benedikt Fischer et al
Letter | 2019
Overdose, Policy/Regulatory, Safer supply, Decriminalization/legalization, Advocacy, Illegal drugs, SCS/OPS

Canada’s Response to the Dual Public Health Crises: A Cautionary Tale

Commentary | 2021
Mortality, Safer supply, Decriminalization/legalization, About prescribers, Illegal drugs, Transitions in care/treatment, Diversion

Considering Heroin-Assisted Treatment and Supervised Drug Consumption Sites in the United States

Given the severity of the opioid crisis, there is urgency to evaluate tools that might reduce its impact and save lives.
Report | 2018
Overdose, Harm reduction, Policy/Regulatory, Safer supply, SCS/OPS

Do naloxone access laws affect perceived risk of heroin use? Evidence from national US data

Assess how implementation of naloxone access laws shapes perceived risk of heroin use.
Original research | 2021
Harm reduction, Hesitancy of prescribers , Advocacy

Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review

We describe new services and service modifications implemented by treatment and harm reduction programs serving PWUO, and discuss implications for policy and practice.

Scoping review | 2021
Evidence base, Policy/Regulatory, Safer supply, About prescribers, Carries/take-home doses

Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis

In response to a dramatic rise in overdose deaths due to injection drug use, there was a rapid scale-up of low-threshold supervised injection services (SIS), termed ‘overdose prevention sites’ (OPS),
Original research | 2021
Harm reduction, About PWUD, Outcomes, Illegal drugs, SCS/OPS

Improved syringe disposal practices associated with unsanctioned safe consumption site use: A cohort study of people who inject drugs in the United States

We evaluated an unsanctioned safe consumption site in an undisclosed United States city in 2018–2020 to assess whether use of the site was associated with improper syringe disposal practices.
Original research | 2021
Evidence base, Outcomes, Illegal drugs, SCS/OPS

Perceived unmet substance use and mental health care needs of acute care patients who use drugs: A cross-sectional analysis using the Behavioral Model for Vulnerable Populations

The perceived unmet service needs of acute care-seeking people who use illegal drugs (PWUD) have been poorly documented, despite evidence of frequent hospital utilisation.
Original research | 2021
Wrap-around services, About PWUD, Social services, Barriers and enablers, Housing, Crime, Illegal drugs, Mental health

Practices of care among people who buy, use, and sell drugs in community settings

We examine the integration of people who sell drugs directly into harm reduction service provision, and their practices of care with other PWUD in their community.
Original research | 2020
Harm reduction, About PWUD, Illegal drugs, Peer/PWLLE program involvement, SCS/OPS, Diversion

Refine Your Search

Keywords
Format
Region